PSP Research »

Immunovant shares owned by PSP Research

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $516k 20k 25.42

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Immunovant

FMR
Deep Track Capital
Vanguard Group
BlackRock
Armistice Capital
Baker Bros. Advisors
T. Rowe Price Investment Management
State Street Corporation
Rtw Investments
Two Seas Capital
Alpine Partners VI
ADAR1 Capital Management
Point72 Asset Management
Woodline Partners
Geode Capital Management

View all funds holding Immunovant